Autor: |
Kolko M; Louisiana State University Health Sciences Center Neuroscience Center of Excellence, 2020 Gravier Street, Suite D, New Orleans, LA 70112, USA., Rodriguez de Turco EB, Diemer NH, Bazan NG |
Jazyk: |
angličtina |
Zdroj: |
Neuroscience letters [Neurosci Lett] 2003 Feb 27; Vol. 338 (2), pp. 164-8. |
DOI: |
10.1016/s0304-3940(02)01385-x |
Abstrakt: |
Activation of cytosolic phospholipase A(2) (cPLA(2)) is an early event in brain injury, which leads to the formation and accumulation of bioactive lipids: platelet-activating factor (PAF), free arachidonic acid, and eicosanoids. A cross-talk between secretory PLA(2) (sPLA(2)) and cPLA(2) in neural signal transduction has previously been suggested (J Biol Chem 271:32722; 1996). Here we show, using neuronal cell cultures, an up-regulation of cPLA(2) expression and an inhibition by the selective cPLA(2) inhibitor AACOCF3 after exposure to neurotoxic concentrations of sPLA(2)-OS2. Pretreatment of neuronal cultures with recombinant PAF acetylhydrolase (rPAF-AH) or the presynaptic PAF receptor antagonist, BN52021, partially blocked neuronal cell death induced by sPLA(2)-OS2. Furthermore, selective COX-2 inhibitors ameliorated sPLA(2)-OS2-induced neurotoxicity. We conclude that sPLA(2)-OS2 activates a neuronal signaling cascade that includes activation of cPLA(2), arachidonic acid release, PAF production, and induction of COX-2. |
Databáze: |
MEDLINE |
Externí odkaz: |
|